Clinical Trials Directory

Trials / Completed

CompletedNCT02065024

Food Matrix and Genetic Variability as Determinants of Bioavailability and Biological Effects of Beta-cryptoxanthin and Phytosterols

Food Matrix and Genetic Variability as Determinants of the Bioavailability and Biological Effects of a B-cryptoxanthin and Phytosterols-enriched Beverage; In Vitro and in Vivo Evaluation

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Puerta de Hierro University Hospital · Academic / Other
Sex
Female
Age
45 Years – 65 Years
Healthy volunteers
Accepted

Summary

Regular consumption of a beverage containing β-cryptoxanthin (b-Cx) and plant sterols (Ps) has been shown to exert a synergic effect in reducing cardiovascular risk and bone remodeling markers (formation and resorption). The present project aims to assess the influence of technological treatment and genetic variability on the bioavailability and the health effects of the added components (Ps, b-Cx), in particular to their potential role in prevalent disorders.In vitro and in vivo studies will be carried out to this effect. In vitro and in vivo studies (human intervention study) will be performed and cardiovascular, bone turnover and inflammation markers will be evaluated. Additionally, an in vitro colonic fermentation model and cell cultures will be used to explore anticarcinogenic effects and potential cytotoxicity.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTb-cryptoxanthin plus phytosterols

Timeline

Start date
2014-03-01
Primary completion
2015-08-01
Completion
2015-08-01
First posted
2014-02-17
Last updated
2018-04-10

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT02065024. Inclusion in this directory is not an endorsement.